baber/WOPTO huggingface dataset:
Patent IL-85336-A0 (IL)
Title: Apparatus for effecting anastomosis of body members
IPC: A61B17/22
Filed: 1988-02-05
Abstract: Apparatus for effecting anastomosis of the distal urethra (U) and the bladder (B) neck includes a tubular ureteral sound (12) with a threaded socket (13) on its distal end. An inflatable anvil (23) is connected to the threaded socket (13) on the ureteral sound (12) through an opening (130) in the urethra (U) adjacent the prostate (P) and the sound (12) is then retracted outwardly to position the inflatable anvil (23) in the urethra (U). A second implement (32) is passed downwardly through an incision (140) in the bladder (B) and is connectable to the inflatable anvil (23) by alignment (108, 110) and locking (96) means following surgical removal of the prostate (P). The inflatable anvil (23) and the second implement (32) respectively mount female (26) and male (28) connector members formed of material which will eventually dissolve in the human body. The male (28) and female (26) connector members are driven toward each other by the second implement (32) and male (28) means penetrates the tissue of the urethra (U) and the bladder (B) neck and then moves into the female (26) connector for engagement with locking means (68, 53) holding the two connector members (26, 28) together to clamp the urethra (U) to the bladder (B) neck to automatically provide an anastomosis. The second implement (32) for severing the tissue in a circular manner, radially inward from the male/female members (26, 28) to provide a clear internal opening (158, 160) for flow from the bladder (B) to the urethra (U). A catheter (30) is attached to the inflatable anvil (23) and upon removal of the second implement (32) is positioned in the bladder (B) which is then closed (151) by conventional surgical procedures. The anvil (23) is deflated and withdrawn outwardly through the urethra (U) to position the catheter (30) for bladder (B) drainage during healing of the anastomosis.
Patent IL-90975-A0 (IL)
Title: Non-glycosylated,recombining human il 2 in reduced form,the process for obtaining it and its use as a medicament
IPC: C07K14/52
Filed: 1989-07-14
Abstract: The invention relates to a nonglycosylated, recombinant human IL2 in which the three cysteines in positions 58, 105 and 125 are in the reduced form and which exhibits a biological activity comparable with that of the oxidised IL2 having the same sequence and containing a disulphide bridge in position 58-105, to the process for obtaining it and to its application as a medication.
Patent IL-91648-A0 (IL)
Title: Amino acid quinoline and naphthyridine derivatives
IPC: C07K5/10
Filed: 1989-09-15
Abstract: 7-(3-A-amino-1-pyrrolidinyl) substituted naphthyridine and quinoline compounds wherein A is a solubilizing group selected from an amino acid residue or polypeptide chain.
Patent IL-92466-A0 (IL)
Title: Arylpiperidine derivatives
IPC: C07D471/04
Filed: 1989-11-27
Abstract: N-alkyl or oxyalkyl arylpiperidine cpds. of formula (I) are new. In (I), Ar = Ph, fluorophenyl, chlorophenyl, trifluoromethylphenyl, methoxyphenyl, tolyl or naphthyl opt. substd. with F, Cl, CF3 or OMe; n= 2-4; X= O, S or a direct bond; R= Ph, hydroxyphenyl, methoxyphenyl, tolyl, 2-amino-4-thiazolylphenyl, 5-oxindolyl, 2-methyl-4-oxo-4H-pyrido (1,2a)pyrimidin-3-yl, 7,9-dioxo-8-azaspiro(4,5)decan-8-yl or 1,8,8-trimethyl-2,4-dioxo -3-azabicyclo(3.2.1)heptan-3-yl. - Also new are arylpiperidine cpds. (II) from which (I) are prepd.. - (I) can be prepd. by reacting (II) with at least an equiv. amt. in moles of an aralkyl (or aryloxyalkyl) or heterocyclyl ether deriv. or corresp. halide of formula: Q(CH2)nXR where Q= a leaving gp. (e.g. p-toluenesulphonyloxy or halogen) in a reaction-inert polar organic solvent (partic. acetone or MIBK), under anhydrous conditions, in the presence of at least an equiv. amt of an appropriate base (partic. Na2CO3 or K2CO3). A temp. of 50-150 deg.C for 2-24 hrs. is used.
Patent FI-20002303-A0 (FI)
IPC: E02D27/12
Filed: 2000-10-18
Abstract: A bracket for supporting a structural element, such as a precast concrete beam, on a concrete pile or similar support structure in a building includes a first support part ( 1 ) which is cast at least partly into the concrete pile. The first support part ( 1 ) includes a bracket part ( 5 ) for supporting the structural element so that the structural element bears against the concrete pile. The bracket part ( 5 ) is movably fastened to the first support part ( 1 ), which is cast at least partly into the concrete pile, such that the position of the bracket part ( 5 ) with regard to the concrete pile can be changed.
Patent FI-20002733-A0 (FI)
Inventor: TASKULA KARI
IPC: G08G1/095
Filed: 2000-12-13
Abstract: An apparatus for monitoring and/or controlling a traffic control light, the light source of said control light consisting of LEDs (2) connected on a circuit board (1), said control light being controlled by means of a control unit, and said control light comprising a lens dome part (3) which is fitted in front of the LEDs and contains transparent light directing elements (4), and said apparatus comprising detectors (5) disposed in connection with the LEDs used as light sources on the same side of the circuit board (1) with these, some of the light reflected from the LEDs being directed to said detectors, which are used to provide optical feedback for the monitoring and/or control of the operation of the control light. The apparatus comprises non-transparent reflectors (6) arranged between the light directing elements to reflect some of the light emitted by the LEDs (2) in the direction of illumination to the detectors (5). <IMAGE>
Patent FI-20021593-A0 (FI)
Inventor: LIUKKO RAIMO
IPC: A23P30/36
Filed: 2002-09-06
Abstract: This invention relates to an edible product with homogeneous consistency containing a starchy vegetable material and having a water content of at least 60% by weight. At least 50%, preferably at least 75% of the cells of this vegetable material are broken, and the amylose contained in the starch is dispersed as amylose particles with a size of less than 10 mum within the amylopectin of the starch. The invention also relates to a process for preparing such a product.
Patent FI-20040575-A0 (FI)
Inventor: SIISKONEN MARKO
IPC: H04W4/00
Filed: 2004-04-23
Abstract: A method provides information on services in a communication system. The method includes obtaining information on services provided via the communication system. The method also includes receiving a request for a service from user equipment. The method also includes verifying, using the information, whether the service is available for the user equipment at a predetermined level. The method also includes performing a further action based on a result of the step of verifying. Furthermore, a service analyzer and a portal are configured to execute the method.
Patent IL-112582-A0 (IL)
Title: Apparatus and process for frying a material from a solution
IPC: F26B5/06
Filed: 1995-02-08
Abstract: PCT No. PCT/IE95/00013 Sec. 371 Date Nov. 4, 1996 Sec. 102(e) Date Nov. 4, 1996 PCT Filed Jan. 31, 1995 PCT Pub. No. WO95/22036 PCT Pub. Date Aug. 17, 1995A process for drying a solution containing the material. The process includes the following steps: (1) subjecting the solution to vacuum-assisted freezing by introducing the solution into an evacuated chamber in the form of a spray, the droplets of which are at a sufficiently low temperature to ensure that they freeze at the vacuum pressure inside the chamber; (2) collecting the frozen droplets of the solution on a collecting surface of the chamber and controlling the temperature of the collecting surface and the pressure within the chamber so that the frozen solvent sublimes from the collected frozen droplets. The collecting surface is prepared by being brought to an initial temperature which is not greater than the melting point of the frozen solution at the initial pressure, which is the pressure within the chamber when the spray is introduced, the temperature of the collecting surface and the pressure within the chamber being maintained throughout the sublimation process so as to prevent partial remelting of the frozen droplets as sublimation occurs
Patent IL-113599-A0 (IL)
Title: Pyrimidine derivatives their preparation and pharmaceutical compositions containing them
IPC: C07D401/04
Filed: 1991-05-31
Abstract: The invention provides a series of compounds of formula (I) <CHEM>  and salts thereof, wherein for example, R<1> and R<2>, which may be the same or different each represent -NR<1><3>R<1><4> where R<1><3> and R<1><4> may each independently represent hydrogen or alkyl or, taken together with the nitrogen atom to which they are attached form a heterocyclic ring, optionally substituted by one or more alkyl or arylalkyl groups and optionally containing a further heteroatom;  R<3> is hydrogen, haloalkyl, alkoxymethyl or alkyl;  R<4> is hydrogen, nitro or halo;  R<5> is hydrogen or halo;  R<6> is hydrogen, halo, nitro, amino, alkylamino or dialkylamino;  R<7> is hydrogen or halo;  R<8> is hydrogen or halo; The compounds may be used for the treatment or prophylaxis of a neurodegenerative or other neurological disorder of the CNS, the aetiology or which includes excessive release of the neurotransmitter glutamate.
Patent IL-126379-A0 (IL)
Title: Wet-process technique for refining phosphoric acid
IPC: C01B25/46
Filed: 1998-02-02
Abstract: A process for purification by multistage countercurrent extraction of wet-process phosphoric acid includes the steps of (a) preparing an aqueous phosphoric acid by decomposition of crude phosphates with sulfuric acid and prepurification thereof; (b) providing an organic solvent mixture consisting of one of (A) a water immiscible solvent and a fully water-miscible solvent or (B) a partially water-miscible solvent and a fully water-miscible solvent; (c) extracting water from the acid by contacting with the solvent mixture in a volumetric ratio of acid to solvent mixture of 1:1 to 1:10 at a temperature of 5 to 90° C.; (d) recovering the fully water-miscible solvent by distillation and washing; (e) recycling the fully water-miscible solvent to step (b) to provide a recycled solvent mixture; and (f) repeating steps (c), (d) and (e) with the recycled solvent mixture to provide a phosphoric acid having a preselected degree of purity.
Patent IL-130331-A0 (IL)
Title: Abradable seal
IPC: F01D5/14
Filed: 1997-12-05
Abstract: An abradable seal is provided utilizing a laser to cut a pattern into the surface effective to improve abradability in the area of the pattern.
Patent IL-131447-A0 (IL)
Title: Combined tumor supressor gene therapy and chemotherapy in the treatment of neoplasms
IPC: A61K31/70
Filed: 1998-02-17
Abstract: In one embodiment, this invention provides methods of treating mammalian cancer or hyperproliferative cells, said method comprising contacting said cells with a tumor suppressor protein or tumor suppressor nucleic acid and also contacting said cell with at least one adjunctive anti-cancer agent. The invention also provides for a pharmacological composition comprising a tumor suppressor protein or a tumor suppressor nucleic acid and at least one adjunctive anti-cancer agent, and a kit for the treatment of mammalian cancer or hyperproliferative cells.
Patent IL-138306-A0 (IL)
Title: Polynucleotide composition, method of preparation and use thereof
IPC: A61K31/7088
Filed: 1999-03-12
Abstract: A lyophilized polynucleotide composition contains at least one polynucleotide and at least one cryoprotectant, wherein the ratio of the polynucleotide to cryoprotectant is from about 0.001 to about 1.0 part by weight polynucleotide per 1.0 part by weight of the cryoprotectant. This composition also contains from about 0.5 weight percent to about (6) weight percent water, based on the total weight of the final lyophilized polynucleotide composition. The polynucleotide composition of this invention is characterized by enhanced stability, in that it retains at least 90% supercoil over a time period of at least (10) days at a temperature of about 37° C. The lyophilized polynucleotide composition also has improved solubility. An improved process for lyophilization of polynucleotides employs a specific primary drying cycle, that results in the above-described stable, lyophilized polynucleotide composition.
Patent IL-144003-A0 (IL)
Title: Compounds and methods for modulation of estrogen receptors
IPC: A61P35/00
Filed: 1999-12-30
Abstract: Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having structure I, as well as pharmaceutical compositions containing the same: wherein R1, R2, R3, n and p are as defined here.  Methods are also disclosed for modulating ER in cells and/or tissues expressing the same, such as bone, breast, prostate, uterus, CNS or the cardiovascular system. Methods for treating estrogen-related conditions are also disclosed, including conditions such as is breast cancer, osteoporosis, endometriosis, cardiovascular disease, hypercholesterolemia, prostatic hypertrophy, prostatic carcinomas, obesity, hot flashes, skin effects, mood swings, memory loss, and adverse reproductive effects associated with exposure to environmental chemicals or natural hormonal imbalances.
Patent IL-145305-A0 (IL)
Title: 4,5-diaryl-3 (2h)-furanone derivatives as cyclooxygenase-2 inhibitors
IPC: A61P25/28
Filed: 2000-04-12
Abstract: The present invention provides a novel class of 4,5-diaryl-3(2H)-furanone derivatives, which inhibit strongly and selectively COX-2 over COX-1. They are useful to treat inflammation, inflammation-associated disorders, and COX-2 mediated diseases.
Patent IL-146369-A0 (IL)
Title: A tear off device for opening drink cans
IPC: B67D3/00
Filed: 2000-03-28
Abstract: A tear-off opening device for drink cans by means of a tab (1) with grip device (2) for tearing, comprising, underneath the tab (1), a shaped lamina (4), secured underneath the lid (6) for a segment (41) which partially surrounds the edge of the opening (3), whilst at least a remaining segment (42) stays free, the lamina (4) having a conformation that is able to vary from a first stable configuration in which, with the can closed, it is drawn up underneath the tab (1), to successive and transitory configurations that take place during the extraction of the lamina (4) through the opening (3) and to a final stable configuration in which, with the extraction completed, the lamina (4) constitutes a stable spout (8) with related opening (9) whose free edges belong to the free segment (42) of the lamina (4).
Patent IL-157123-A0 (IL)
Title: Microelectronic system with integral cyrocooler, and its fabrication and use
IPC: H01L23/44
Filed: 2002-08-29
Abstract: A gas-expansion cooler assembly has an expansion structure with an expansion orifice and an expansion reservoir in fluid-flow communication with an expansion-orifice outlet. A heat exchanger has a heat-exchanger inlet, and a heat-exchanger outlet in fluid-flow communication with the expansion-orifice inlet. The heat exchanger includes at least two heat-exchanger plates stacked in a facing relationship along an assembly axis. Each heat-exchanger plate includes an in-plane channel lying substantially in a plane perpendicular to the assembly axis. The in-plane channels of the adjacent heat-exchanger plates are in fluid-flow communication with each other and with the expansion-orifice inlet to form a continuous high-pressure fluid-flow path from the heat-exchanger inlet to the expansion-orifice inlet. The heat exchanger further includes an axial channel extending parallel to the assembly axis. The axial channels in the adjacent heat-exchanger plates are in fluid-flow communication with each other and with the expansion reservoir to form a continuous exhaust fluid-flow path from the expansion reservoir to an exhaust port.
Patent IL-159047-A0 (IL)
Title: Pharmacological applications of mitochondrial dna assay
IPC: C12Q1/6876
Filed: 2002-05-29
Abstract: The invention provides assays to determine the relative amount of mitochondrial DNA in a subject, such as a subject undergoing drug treatment. The subject may for example be a human patient undergoing treatment for an HIV infection with a nucleic acid precursor such as a nucleoside or nucleotide analogue. The assays of the invention may include PCR assays, such semi-quantitative or quantitative PCR involving the co-amplification of a mitochondrial sequence and a reference sequence, such as a genomic sequence. Information from such assays may be evaluated to provide a ratio of mitochondrial DNA to nuclear DNA in the cells of the subject.
Patent IL-162152-A0 (IL)
Title: Tissue inhibitor metalloproteinase type three (timp-3) composition and methods
IPC: A61K48/00
Filed: 2004-05-24
Abstract: Provided herein are metalloproteinase inhibitors and polynucleotides encoding such factors. In particular, provided herein are novel mammalian tissue inhibitors of metalloproteinase (designated as type three, or "TIMP-3"), fragments, derivatives, and analogs thereof, polynucleotides encoding the same and methods of producing recombinant TIMP-3's. In a further aspect, pharmaceutical compositions and kits containing TIMP-3's and their use for treating disorders are provided herein. In yet another aspect, antibodies selectively binding TIMP-3's are provided.
Patent IL-162271-A0 (IL)
Title: Pharmaceutical dosage form and method for the production thereof
IPC: A61J3/06
Filed: 2003-01-30
Abstract: The invention relates to a method for producing a pharmaceutical dosage form as tablets, pellets and/or in the form of an active ingredient-containing matrix, whereby the tablets, pellets and/or active ingredient-containing matrix contain a pharmaceutical active ingredient and a copolymer serving as a coating agent and/or binding agent, and optionally contain a core and pharmaceutically common additives. According to the invention, the copolymer, the pharmaceutical active ingredient, the optionally present core and/or the pharmaceutically common additives are processed using known techniques by melting, injection molding, extrusion, wet granulation, casting, dipping, spreading out, spraying on, or pressing to form tablets, pellets and/or an active ingredient-containing matrix. The inventive method is characterized in that a copolymer is used that consists of 20 to 34 wt. % methacrylic acid, 20 to 69 wt. % methylacrylate and 0 to 40 wt. % ethylacrylate and, optionally, of 0 to 10 wt. % of additional vinylically copolymerizable monomers with the provision that the glass transition temperature of the copolymer is no higher than 60° C. according to ISO 11357-2, Item 3.3.3. The invention also relates to the pharmaceutical dosage form produced according to this method, said copolymer and the use thereof.
Patent IL-174955-A0 (IL)
Title: Method for manufacturing an electrochemical-based analytical test strip with hydrophilicity enhanced metal electrodes
Filed: 2006-04-11
Abstract: A method for manufacturing a portion of an electrochemical-based test strip comprising includes forming a metal electrode(s) with an upper surface on a surface of an electrically-insulating substrate. The method also includes treating the upper surface of the metal electrode(s) with a hydrophilicity-enhancing composition to form a treated upper surface on the metal electrode with hydrophilicity-enhancing chemical moieties thereon and depositing an enzymatic reagent layer on the treated upper surface of the metal electrode(s).
Patent IL-183470-A0 (IL)
Title: Managing multiprocessor operations
Filed: 2007-05-28
Abstract: In managing multiprocessor operations, a first processor repetitively reads a cache line wherein the cache line is cached from a line of a shared memory of resources shared by both the first processor and a second processor. Coherency is maintained between the shared memory line and the cache line in accordance with a cache coherency protocol. In one aspect, the repetitive cache line reading occupies the first processor and inhibits the first processor from accessing the shared resources. In another aspect, upon completion of operations by the second processor involving the shared resources, the second processor writes data to the shared memory line to signal to the first processor that the shared resources may be accessed by the first processor. In response, the first processor changes the state of the cache line in accordance with the cache coherency protocol and reads the data written by the second processor. Other embodiments are described and claimed.
Patent IL-197534-A0 (IL)
Title: Energy storage module
Filed: 2009-03-11
Abstract: Energy storage modules generally include a housing with component parts arranged therein. The component parts are in this case either capacitors, for example double-layer capacitors and/or electrolyte capacitors. According to the invention, a filler is provided in the housing and binds electrolyte liquid occurring in the even of damage or else electrolyte gases. Beds of material with a large specific surface area, such as zeolites or else active carbons, are suitable as fillers. The surfaces are also possibly catalytically coated.
Patent RO-129054-A0 (RO)
Title: Method and device for progressive correction of plantar problems
Inventor: BRAUN BARBU-CRISTIAN
IPC: A43B7/14
Filed: 2013-04-23
Abstract: The invention relates to a method and a device which is an orthosis for the progressive correction of certain plantar problems, such as: flat feet, high arches, hallux valgus. According to the invention, the method consists in taking over data from a sensorial system indicating the number of steps, the time required for making them and the curvature change in the orthosis plantar zone, with a view to enabling the orthosis self-adjustment so as to meet the subject's recovery requirements. According to the invention, the device is an orthosis which is included within the footwear sole (1) and comprises two micro contact sensors (2, 3) positioned at the front and back parts of the sole, intended to indicate the number of steps made by the subject, their frequency, the distance, speed and theoretical acceleration of motion and the number of steps made upon running or walking, a tensometric sensor (4) indicating the pressure exerted on the subject's sole in the medial zone, used in monitoring the sole curvature evolution, an electronic system provided with a micro controller (5) capable of taking over and interpreting the data received from the sensors (2, 3, 4) and of sending control signals for a piezoelectric micro pump actuator (6) with a view to progressively changing the medial curvature (7) of the orthosis, depending on the degree of correction of the subject's plantar affection, by filling a silicone container (8) with liquid, a mechanical system including the electronics, a micro pump (6), a liquid reserve (9) and a battery (10) which supplies the micro controller (5) and the micro pump (6).
Patent RO-131499-A0 (RO)
Title: Process for biorefining sugar-bearing plants and extracting sugars for preparation of biofuels and other biocompounds
Inventor: VINTILĂ TEODOR VASILE
IPC: C12P7/10
Filed: 2016-05-11
Abstract: The invention relates to a process for biorefining sugar-bearing plants for biofuels preparation. According to the invention, the process comprises the following steps : a. disintegrating the sugar plant biomass into fragments of 0.2...1 cm and silaging them in the presence of an aqueous ethanol solution; b. extracting a first portion of sugars; c. adding an ethanol solution and harvesting a new portion of sugars; d. repeating the extraction up to a concentration of minimum 40 mg/ml sugars in the extract; e. recovering the ethanol from the extract; f. fermenting the portions of sugar solutions; g. separating the fermentation products and using them; h. enzymatically hydrolyzing a bagasse resulted after the extraction of sugars and fermenting the hydrolysate for preparing the lignocellulose ethanol; i. separating the ethanol and j. anaerobically digesting the liquid residue from steps g. and i. and solid residue from the preparation of lignocellulose ethanol to result in biogas and organic fertilizer.